![]() |
Volumn 485, Issue 7400, 2012, Pages S58-S59
|
Perspective: The right trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
TAMOXIFEN;
TRASTUZUMAB;
CANCER;
CYTOLOGY;
DISEASE PREVALENCE;
DISEASE TREATMENT;
GROWTH REGULATOR;
INHIBITION;
MEDICINE;
MORTALITY;
RESEARCH WORK;
SURVIVAL;
TUMOR;
WOMENS HEALTH;
BRAIN METASTASIS;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER GROWTH;
CANCER INHIBITION;
CANCER INVASION;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SURGERY;
CLINICAL TRIAL (TOPIC);
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
GENE MUTATION;
HUMAN;
METASTASIS;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
REVIEW;
ANTIBODIES, MONOCLONAL;
BREAST NEOPLASMS;
CLINICAL TRIALS AS TOPIC;
DRUG INDUSTRY;
FEMALE;
HUMANS;
NEOPLASM METASTASIS;
RESEARCH DESIGN;
SENTINEL LYMPH NODE BIOPSY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84861716177
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/485S58a Document Type: Article |
Times cited : (65)
|
References (5)
|